Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2558)
All Articles published online
|
Publishing Process of This Article
|
Aug 27, 2022 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahmed F, Zakaria F, Enebong Nya G, Mouchli M. Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma? World J Gastrointest Surg 2022; 14(8): 862-866 [PMID: 36157369 DOI: 10.4240/wjgs.v14.i8.862] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i8/862.htm |
| Number | Citing Articles |
| 1 |
Mohamed E. Nady, Ola M. Abd El-Raouf, El-Sayed M. El-Sayed. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09533-2
|